Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)
Conditions:   Rhinitis, Allergic, Seasonal;   Rhinitis, Allergic, Perennial;   UrticariaIntervention:   Drug: Desloratadine SyrupSponsor:   Merck Sharp & Dohme Corp.Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2008 Category: Research Source Type: clinical trials

Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)
Conditions:   Chronic Idiopathic Urticaria;   AtopyInterventions:   Drug: desloratadine;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2008 Category: Research Source Type: clinical trials

A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)
Condition:   UrticariaInterventions:   Drug: desloratadine;   Drug: placebo;   Drug: cetirizineSponsor:   Merck Sharp & Dohme Corp.Completed - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 10, 2008 Category: Research Source Type: clinical trials

Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)
Condition:   RhinitisIntervention:   Drug: Desloratadine (assigned by investigator as part of normal practice)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2008 Category: Research Source Type: clinical trials

Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)
Condition:   Chronic Idiopathic UrticariaInterventions:   Drug: 5-mg Desloratadine;   Drug: 10-mg Desloratadine;   Drug: 20-mg DesloratadineSponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2007 Category: Research Source Type: clinical trials

Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)
Condition:   Allergic RhinitisInterventions:   Drug: 5-mg Desloratadine;   Drug: Placebo tabletSponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2006 Category: Research Source Type: clinical trials